Glomerular paramesangial deposits: Association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III

American Journal of Kidney Diseases

Volumn 31, Issue 3, 1998, Pages 427-434

  West, Clark D ^a,b   McAdams, A James ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

C3; Factor H; Hypocomplementemia; MPGN; Nephritic factors; Paramesangial glomerular deposits

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; GLOMERULUS CAPILLARY; HUMAN; HUMAN TISSUE; HYPOCOMPLEMENTEMIA; KIDNEY BIOPSY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM; PATHOPHYSIOLOGY;

EID: 0031939672     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9506679     Document Type: Article

References (28)

1. West CD: Nephritic factors predispose to chronic glomerulonephritis. Am J Kidney Dis 24:956-963, 1994
2. Marder HK, Coleman TH, Forristal J, Beischel L, West CD: An inherited defect in the C3 convertase, C3b, Bb, associated with glomerulonephritis. Kidney Int 23:749-758, 1983
3. Linshaw MA, Stapleton FB, Cuppage FE, Forristal J, West CD, Schreiber RD, Wilson CB: Hypocomplementemic glomerulonephritis in an infant and mother. Evidence for an abnormal form of C3. Am J Nephrol 7:470-477, 1987
4. West CD, McAdams AJ: Paramesangial glomerular deposits in membranoproliferative glomerulonephritis type II correlate with hypocomplementemia. Am J Kidney Dis 25:853-861, 1995
5. Weiler JM, Daha MR, Austen KF, Fearon DT: Control of the amplification convertase of complement by the plasma protein beta-lH. Proc Natl Acad Sci U S A 73:3268-3272, 1976
6. Daha MR, Fearon DT, Austen KF: C3 nephritic factor (C3 NeF): Stabilization of fluid phase and cell bound alternative pathway convertase. J Immunol 116:1-7, 1976
7. Daha MR, Austen KF, Fearon DT: The incorporation of C3 nephritic factor (C3 NeF) into a stabilized C3 convertase, C3bBb (C3 NeF), and its release after decay of convertase function. J Immunol 119:812-817, 1977
8. Peters DK, Gwyn Williams D: Complement and mesangiocapillary glomerulonephritis. Role of complement deficiency in the pathogenesis of nephritis. Nephron 13:187-197, 1974
9. Habib R, Gubler M-C, Loirat C, Ben Maiz H, Levy M: Dense deposit disease: A variant of membranoproliferative glomerulonephritis. Kidney Int 7:204-215, 1975
10. Vargas R, Thomson KJ, Wilson D, Cameron JS, Turner DR, Gill D, Chantler C, Ogg CS: Mesangiocapillary glomerulonephritis with dense "deposits" in the basement membranes of the kidney. Clin Nephrol 5:73-82, 1976
11. Lamb V, Tisher CC, McCoy RC, Robinson RR: Membranoproliferative glomerulonephritis with dense intramembranous alterations. A clinicopathologic study. Lab Invest 36:607-616, 1977
12. Clardy CW, Forristal J, Strife CF, West CD: A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III. Clin Immunol Immunopathol 50:333-347, 1989
13. Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M: The effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro. Clin Exp Immunol 65:73-79, 1986
14. Tanuma Y, Ohi H, Hatano M: Two types of C3 nephritic factor: Properdin-dependent C3 NeF and properdin-independent C3 NeF. Clin Immunol Immunopathol 56:226-238, 1990
15. Varade WS, Forristal J, West CD: Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III. Am J Kidney Dis 16:196-206, 1990
16. Clardy CW, Forristal J, Strife CF, West CD: Serum terminal complement component levels in hypocomplementemic glomerulonephritides. Clin Immunol Immunopathol 50:307-310, 1989
17. Jackson EC, McAdams AJ, Strife CF, Forristal J, Welch TR, West CD: Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation. Am J Kidney Dis 9:115-120, 1987
18. West CD, McAdams AJ: The chronic glomerulonephritides of childhood. Part II. J Pediatr 93:167-176, 1978
19. Strife CF, McEnery PT, McAdams AJ, West CD: Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane. Clin Nephrol 7:65-72, 1977
20. McAdams AJ, McEnery PT, Bove KE, West CD: Childhood nephritis, in Rosenberg AH, Bolandi RP (eds): Perspectives in Pediatric Pathology. Chicago, IL, Yearbook Medical, 1973, pp 189-225
21. Bariety J, Callard P: Striated membranous structures in renal glomerular tufts. An electron microscopy study of 340 human renal biopsies. Lab Invest 32:636-641, 1975
22. McEnery PT, McAdams AJ, West CD: The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopalhic membranoproliferative glomerulonephritis. Medicine (Baltimore) 64:401-424, 1985
23. Vallota EH, Forristal J, Spitzer RE, Davis NC, West CD: Characteristics of a non-complement dependent C3-reactive complex formed from factors in nephritic and normal serum. J Exp Med 131:1306-1334, 1970
24. Sissons JGP, West RJ, Fallows J, Williams DG, Boucher BJ, Amos N, Peters DK: The complement abnormalities of lipodystrophy. N Engl J Med 194:461-465, 1976
25. Sissons JGP, Liebowitch D, Amos N, Peters DK: Metabolism of the fifth component of complement and its relation to the metabolism of the third component in patients with complement activation. J Clin Invest 59:704-715, 1977
26. Charlesworth JA, Gwyn William D, Sherington E, Lachmann PS, Peters DK: Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest 53:1578-1587, 1974
27. Michael AF, Herdman RC, Fish AJ, Pickering RJ, Vernier RL: Chronic membranoproliferative glomerulonephritis with hypocomplementemia. Transplant Proc 1:925-932, 1969
28. Strife CF, McDonald BM, Ruley EJ, McAdams AJ, West CD: Shunt nephritis: The nature of the serum cryoglobulins and their relation to the complement profile. J Pediatr 88:403-413, 1976